Q1 2024 Holdings
Filed 2024-05-15 | 33 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology, Inc.(CGON) | COMM | 156944100 | $156.7M | 3,570,206 | 12.4% |
| Dyne Therapeutics, Inc(DYN) | COMM | 26818M108 | $75.2M | 2,650,150 | 5.9% |
| Astria Therapeutics, Inc.(CATBUSD) | COMM | 04635X102 | $74.3M | 5,278,928 | 5.9% |
| Silence Therapeutics PLC(SLN) | ADRS | 82686Q101 | $71.2M | 3,295,350 | 5.6% |
| Structure Therapeutics Inc(GPCR) | ADRS | 86366E106 | $68.5M | 1,598,421 | 5.4% |
| Aerovate Therapeutics Inc | COMM | 008064107 | $65.1M | 2,201,274 | 5.1% |
| Inhibrx,inc(INBXUSD) | COMM | 45720L107 | $61.2M | 1,750,387 | 4.8% |
| Keros Therapeutics, Inc.(KROS) | COMM | 492327101 | $58.2M | 879,344 | 4.6% |
| Geron Corp(GERN) | COMM | 374163103 | $57.4M | 17,391,639 | 4.5% |
| Savara Inc.(SVRA) | COMM | 805111101 | $49.8M | 10,000,000 | 3.9% |
| Ocular Therapeutix, Inc.(OCUL) | COMM | 67576A100 | $48.4M | 5,319,148 | 3.8% |
| Cogent Biosciences Inc(COGT) | COMM | 19240Q201 | $41.8M | 6,214,375 | 3.3% |
| Edgewise Therapeutics, Inc.(EWTX) | COMM | 28036F105 | $41.5M | 2,272,728 | 3.3% |
| Mineralys Therapeutics, Inc.(MLYS) | COMM | 603170101 | $41.1M | 3,185,185 | 3.3% |
| Madrigal Pharmaceuticals Inc(MDGL) | COMM | 558868105 | $39.9M | 149,283 | 3.2% |
| Tourmaline BIO Inc(TRML) | COMM | 89157D105 | $33.8M | 1,477,593 | 2.7% |
| Tyra Biosciences Inc(TYRA) | COMM | 90240B106 | $32.6M | 1,989,103 | 2.6% |
| Compass Pathways PLC(CMPS) | ADRS | 20451W101 | $32.1M | 3,858,000 | 2.5% |
| Kura Oncology Inc(KURA) | COMM | 50127T109 | $30.4M | 1,423,642 | 2.4% |
| Tarsus Pharmaceuticals, Inc.(TARS) | COMM | 87650L103 | $28.9M | 793,829 | 2.3% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | COMM | 00773U108 | $28.4M | 2,008,340 | 2.2% |
| Soleno Therapeutivs, Inc. | COMM | 834203200 | $23.5M | 550,000 | 1.9% |
| Centessa Pharmaceuticals PLC(CNTA) | COMM | 152309100 | $23.1M | 2,040,816 | 1.8% |
| Abivax SA(ABVX) | ADRS | 00370M103 | $15.7M | 1,100,000 | 1.2% |
| Vistagen Therapeutics Inc(VTGNUSD) | COMM | 92840H202 | $14.1M | 2,676,580 | 1.1% |
| Kalvista Pharmaceuticals, Inc(KALV) | COMM | 483497103 | $13.8M | 1,163,356 | 1.1% |
| C4 Therapeutics, Inc.(CCCC) | COMM | 12529R107 | $10.4M | 1,276,574 | 0.8% |
| Entrada Therapeutics Inc(TRDA) | COMM | 29384C108 | $8.3M | 584,955 | 0.7% |
| An2 Therapeutics, Inc.(ANTX) | COMM | 037326105 | $5.1M | 1,555,118 | 0.4% |
| Kodiak Sciences Inc(KOD) | COMM | 50015M109 | $4.7M | 899,999 | 0.4% |
| Ventyx Biosciences, Inc(VTYX) | COMM | 92332V107 | $4.5M | 815,724 | 0.4% |
| Nektar Therapeutics(NKTREUR) | COMM | 640268108 | $3.7M | 4,000,000 | 0.3% |
| Cabaletta BIO, Inc(CABA) | COMM | 12674W109 | $1.5M | 86,795 | 0.1% |